Characterization of TP53 Mutations in Actionable Driver-negative Non-Small Cell Lung Cancer NSCLC | Caris Life Sciences
Home / Research / Publications / Characterization of TP53 Mutations in Actionable Driver-negative Non-Small Cell Lung Cancer NSCLC

Publications

Characterization of TP53 Mutations in Actionable Driver-negative Non-Small Cell Lung Cancer NSCLC

Background

  • Despite the increased prevalence in actionable driver-negative (DN) NSCLC, the role ofTP53mutations in this subtype is not fully explored.
  • We characterize the association ofTP53mutations with the molecular and immune landscapes, as well as outcomes, in in the context of histologic subtypes.
Download Publication
Learn More
Name(Required)